Difficulty: Medium
Average Score: 83%
Practice
Which of the following may increase seizure activity in epileptic patients?
Correct answer
D
Rationale
In the context of pharmacology of CNS drugs, understanding how different medications can affect seizure activity in epileptic patients is crucial. In this question, the correct answer is D) L-Dopa, which may increase seizure activity in epileptic patients.
L-Dopa is a precursor to dopamine and is used in the treatment of Parkinson's disease. However, in epileptic patients, it can lower the seizure threshold, leading to an increased risk of seizures. This occurs due to the way L-Dopa interacts with neurotransmitters in the brain, potentially triggering abnormal electrical activity that can manifest as seizures.
Now, let's discuss why the other options are incorrect:
A) Ethotoin and B) Phenobarbital are antiepileptic drugs commonly used to control seizures in epileptic patients. They work by stabilizing neuronal membranes and reducing excessive electrical activity in the brain, thus decreasing the likelihood of seizures.
C) Trihexyphenidyl is an anticholinergic medication primarily used to treat symptoms of Parkinson's disease and drug-induced extrapyramidal symptoms. While it does not directly increase seizure activity, it is not typically associated with seizure control either.
Educationally, this question highlights the importance of understanding how different medications can have varying effects on seizure activity in epileptic patients. It reinforces the need for healthcare providers to consider a patient's complete medication regimen and medical history when prescribing drugs that may impact seizure risk. This knowledge is essential for safe and effective pharmacological management of patients with epilepsy.
L-Dopa is a precursor to dopamine and is used in the treatment of Parkinson's disease. However, in epileptic patients, it can lower the seizure threshold, leading to an increased risk of seizures. This occurs due to the way L-Dopa interacts with neurotransmitters in the brain, potentially triggering abnormal electrical activity that can manifest as seizures.
Now, let's discuss why the other options are incorrect:
A) Ethotoin and B) Phenobarbital are antiepileptic drugs commonly used to control seizures in epileptic patients. They work by stabilizing neuronal membranes and reducing excessive electrical activity in the brain, thus decreasing the likelihood of seizures.
C) Trihexyphenidyl is an anticholinergic medication primarily used to treat symptoms of Parkinson's disease and drug-induced extrapyramidal symptoms. While it does not directly increase seizure activity, it is not typically associated with seizure control either.
Educationally, this question highlights the importance of understanding how different medications can have varying effects on seizure activity in epileptic patients. It reinforces the need for healthcare providers to consider a patient's complete medication regimen and medical history when prescribing drugs that may impact seizure risk. This knowledge is essential for safe and effective pharmacological management of patients with epilepsy.